Endocrine Surgery — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, training, satisfaction, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Subspecialty fellowship of General Surgery (AAES-accredited).

Also called: endocrine surgery, surgical endocrinology, "comprehensive endocrine surgery." Reached through general surgery, so you finish a general surgery residency first and then do a 1-year fellowship. Organ systems: the endocrine glands you can operate on, meaning thyroid, parathyroid, adrenal, and neuroendocrine (pancreas and GI) tumors.

The 30-second version

Endocrine surgery is the elegant, low-emergency corner of the operating world, a largely elective and outpatient-heavy practice built around three glands: the thyroid, the parathyroid, and the adrenal (plus neuroendocrine tumors). The bread-and-butter operations are short, refined, and planned in advance; true emergencies are rare; and the outcomes are often immediate and gratifying: you cure a cancer while preserving someone's voice, or reverse years of hormone-driven fatigue with a focused parathyroidectomy the patient feels within days. You reach it through a standard general surgery residency plus one extra fellowship year, and the reward is one of the most controllable lives in surgery. The honest catch is structural, not personal: it's a small, referral-dependent niche, so the good (and most purely-endocrine) jobs concentrate at academic and high-volume centers, which can pin down where you're able to live.12

Quick dashboard (details and sources below)
Training after med school GS residency (5) + Endocrine Surgery fellowship (1) = 6 yrs after med school (7 with an optional research year)
Total from college start ~14 years (4 undergrad + 4 med school + 5 GS residency + 1 fellowship)
Accreditation / boarding Fellowship is AAES-accredited, non-ACGME; graduates are general-surgery boarded (ABS) — there is no separate endocrine-surgery board certificate
Competitiveness (as a surgical fellowship) Small niche — ~28–30 fellows/yr across ~28 programs; own AAES match, historically ~1:1 applicant-to-position ⟳
Typical full-time pay ~$400,000–$550,000 total comp (anchored to general surgery; no endocrine-specific survey) ⟳
Pay range (structure) Academic ~$350k–$450k · community/employed ~$400k–$500k · private/partnership ~$500k–$700k+ — an order of magnitude rather than survey medians; the source was an aggregator blog and it is dead ⟳
Lifestyle Among the most schedule-friendly in surgery — elective, outpatient-heavy, light non-emergent call
Burnout Not broken out alone; profile lines up with the lower-burnout surgical group. Parent general surgery is 43.8% against a 41.9% all-physician average (AMA 2025) ⟳
% women ~54% of fellowship applicants in the last published cohort (2009–2013) — high for surgery ⟳
DO / IMG accessibility Historically an overwhelmingly US-MD field (~95% MD, ~5% IMG, ~0% DO in 2009–2013 cohort) ⟳

What they actually do

Endocrine surgeons operate on the hormone-producing glands: the thyroid (goiters, nodules, thyroid cancer, Graves'), the parathyroid (primary hyperparathyroidism), the adrenal (functional tumors such as aldosteronoma, Cushing's, and pheochromocytoma), and neuroendocrine tumors of the pancreas and GI tract. Much of the work is a puzzle before it's an operation: you're synthesizing labs (hormone levels), imaging (ultrasound, sestamibi, cross-sectional scans), and genetics into a diagnosis, then deciding whether and how to operate. A large share of the job is actually clinic: counseling patients, working up nodules, and managing the multidisciplinary picture alongside endocrinologists and oncologists.12

The operations themselves are refined rather than heavy. Thyroidectomy and parathyroidectomy are typically short (often 1–4 hours), frequently outpatient or short-stay, and elective. The signature skill is fine, careful dissection in a small, nerve-dense space, and protecting the recurrent laryngeal nerve (which controls the voice) is so central that intraoperative nerve monitoring has become routine.2 Adrenal and neuroendocrine cases run higher in acuity and complexity. Because complication rates fall sharply with surgeon volume, the field openly organizes itself around high-volume centers.2

Representative procedures: total and partial thyroidectomy · focused and four-gland parathyroidectomy (often with rapid intraoperative PTH assay to confirm cure in the OR) · laparoscopic/minimally invasive adrenalectomy · central and lateral neck dissection for thyroid cancer · resection of pancreatic/GI neuroendocrine tumors · reoperative neck surgery (fixing prior failed operations) · intraoperative recurrent-laryngeal-nerve monitoring · surgery for hereditary endocrine syndromes (MEN1/MEN2).2

A week in the life: A common attending template is roughly two OR days, two clinic days, and one administrative/academic day. OR days are stacked with planned cases; clinic days run something like 8:30–3:30 seeing a dozen-plus patients: nodules, post-op checks, and a lot of counseling. The inpatient census stays light because so much is outpatient or short-stay, and you rarely get pulled back overnight, since genuine endocrine emergencies (an airway-threatening neck bleed, a pheochromocytoma hypertensive crisis) are uncommon. The important caveat: this "protected" rhythm assumes a focused endocrine practice. An endocrine surgeon in a broader community general-surgery job may still share general and trauma call. The civilized schedule is real, but it comes with the focused academic and high-volume practice, not automatically.12

The training path & time to completion

Medical school (4 yrs) → General Surgery residency (5 yrs, ACGME) → Endocrine Surgery fellowship (1 yr, AAES-accredited, non-ACGME) → practice as a general-surgery-boarded surgeon who subspecializes. You do not enter endocrine surgery from medical school. It is reached through general surgery. That means the decision often happens mid-residency: in the last published applicant cohort, only 5% entered residency specifically intending to do endocrine surgery, and most decided along the way.34

  • The extra tail is short. Comprehensive endocrine surgery is typically a single fellowship year ("comprehensive clinical fellowship"), with an optional second year for research or academic development at some programs, a shorter and cheaper add-on than many surgical fellowships.3
  • Accreditation is unusual, so read this carefully. Endocrine surgery fellowships are accredited by the American Association of Endocrine Surgeons (AAES), not the ACGME. The AAES describes them as "non-ACGME fellowship programs facilitating greater flexibility and independence in training," and states plainly that any endocrine surgery fellowship not on its list is not AAES-accredited.3 The AAES runs its own match (separate from the NRMP).3
  • Boarding. Graduates are board-certified in general surgery through the American Board of Surgery (ABS). There is no separate ABS subspecialty certificate in endocrine surgery. It is a fellowship-defined subspecialty rather than a boarded one. Fellowship applicants must have completed an accredited general surgery residency and be ABS board-certified or board-eligible.3
  • Total from the start of college: ~14 years (4 undergrad + 4 med school + 5 GS residency + 1 fellowship); 15 if you take the optional research year.3

How competitive is it?

Endocrine surgery presents the opposite shape of problem from the fiercely contested residencies premeds usually worry about. It is one of the smallest surgical fellowship niches, roughly 28–30 fellows per year across ~28 programs (US + Canada, plus a program in Mexico City), and it runs its own AAES match rather than going through the NRMP.3

What that means:

  • Positions have grown modestly: ~25 programs/25 fellows in the 2023 match, up toward ~29 positions filled (2025) and 28 institutions with matched fellows (2026).3 ⟳
  • The ratio is close to 1:1. Historically the fill rate is high and applicants-to-positions run close to even, a small and mutually-selective field rather than a crush. A national survey of the 2009–2013 fellow cohort found a 100% first-attempt match rate, with 96% matching within their top 5 programs.4 ⟳
  • Recent-cycle total applicant counts aren't published on the public AAES pages, so treat any precise "applicant pool" number with caution.3 ⟳
  • The applicant profile is academically loaded. In that same cohort, successful applicants had a median of 5 publications (median 2 first-author), 62% had dedicated research time, mean age 33, 26% AOA, and 77% obtained a recommendation letter from an AAES member, so the real "competitiveness" here is less about crushing a match algorithm and more about building an academic, research-flavored profile inside general surgery and getting known within a small society.4 ⟳

The honest read: the harder gate is general surgery itself (a full, competitive 5-year residency). Once you're a strong general surgery resident with research and AAES connections, the fellowship itself is a small, reachable, well-matched field, but you're committing to the surgical training pipeline first.

Compensation — the robust version

Start with a blunt data caveat, because it shapes everything below: no major national salary survey (Doximity, Medscape, MGMA public tiers, BLS) breaks out "endocrine surgery" as a distinct line. The cohort is too small, at a few hundred fellowship-trained endocrine surgeons nationally, overwhelmingly at academic and tertiary referral centers. So compensation is best understood by anchoring to General Surgery (the training base and the RVU/benchmark category most endocrine surgeons are actually paid under) and adjusting for the field's high-volume outpatient case mix and academic tilt. Job-board aggregators that do print an "Endocrine Surgeon" number pull in mislabeled endocrinology/advanced-practice postings and materially understate the specialist, so those are flagged as outliers rather than the norm.56

National number (via the general-surgery anchor). General surgery lands at roughly $442,000 (Medscape 2025) and $482,574 (Doximity 2025, 2024 data).567 Endocrine surgeons in high-volume thyroid/parathyroid/adrenal practices generally earn comparable to, or somewhat above, general surgery, offset downward by the field's academic tilt. A defensible synthesized "typical full-time" figure for 2025–26 is ~$400,000–$550,000 total compensation, with very high-volume operative practices reaching $550k–$650k+ and purely-academic/low-volume roles in the $350k–$450k band.5 (This is an analyst synthesis from the general-surgery anchor and practice-setting data; no survey publishes an endocrine-specific mean.) ⟳

The spread (by setting, general-surgery frame), and read the sourcing before the numbers. Academic medicine $350,000–$450,000 · community/hospital-employed $400,000–$500,000 · private practice/partnership $500,000–$700,000+. These three bands, the highest-paying-states list below and the ~20–30% rural premium below all trace to one aggregator blog that is now dead, so treat them as an order of magnitude and not as survey medians.8 Because endocrine surgery sits disproportionately in the academic/tertiary band, much of the field clusters toward the lower of those ranges, the trade-off you accept for the referral funnel and case volume that make a focused endocrine practice possible.5 ⟳

Setting matters more than seniority here. The dominant lever is practice model and, above all, case volume, rather than years in practice. Endocrine surgery is predominantly academic-faculty and hospital/health-system employed, with a smaller share in high-volume private or single-specialty groups. Pay is typically base salary + wRVU productivity incentive ± academic/administrative components. Because per-case wRVUs are relatively low (short outpatient operations), earnings are driven strongly by case volume and clinic throughput, and the highest earners run very high-volume thyroid and parathyroid practices.5

A structural quirk: wRVU models can undercompensate this field. The AAES published a formal statement on clinical productivity and compensation for endocrine surgeons (Surgery, 2026) flagging that standard wRVU-based pay can disadvantage endocrine surgeons, because their high-volume, shorter thyroid/parathyroid outpatient cases generate fewer wRVUs per hour than higher-acuity general-surgery operations, so pure wRVU targets can undercount a genuinely busy endocrine practice.9 This is a live comp issue rather than a footnote, and it is exactly why "volume" and how your contract counts it matter more here than in most fields. ⟳

Geography follows the referral base, not the rural premium. No endocrine-specific geographic breakdown is published. General surgery's highest-paying states run California, New York, New Jersey, Washington, Florida, and general surgery carries rural/shortage-area premiums of ~20–30% plus loan-forgiveness incentives.8 But here's the endocrine-specific twist: that rural premium mostly doesn't apply, because endocrine surgery needs a referral base and is rarely practiced rurally. It clusters in major-metro academic and tertiary centers. So unlike general surgery (where the money can be where the desirability is lowest), endocrine surgery's geography skews toward large urban markets by structural necessity.5 ⟳

The aggregator trap (do not use these as the norm). ZipRecruiter's US "Endocrine Surgeon" figure of a ~$285,176 national average, range $100k–$399k, ~$137/hr, reflects scraped, mixed postings and materially understates fellowship-trained pay.10 Treat it as an example of why you anchor to general surgery, not as a salary. ⟳

The trend backdrop. Overall physician pay rose a modest +3.7% in 2024 (down from +5.9% in 2023), and Medscape 2026 framed comp as "normalizing," with gains barely outpacing inflation.711 More pointedly for this field, a 2.5% wRVU cut on nearly all non-time-based CPT codes took effect Jan 1, 2026, pressuring wRVU-based surgical pay and prompting benchmark-recalibration debate, a direct headwind for endocrine surgeons paid on wRVU targets.12 ⟳

Lifestyle & the trade

The single most-cited pro of endocrine surgery: it's one of the most controllable lives in the operating world. The core operations are elective, short, and often outpatient; you largely control your OR calendar; the inpatient census stays light; and true emergencies are rare, so nights and weekends are mostly your own.12 Fellowship weeks around 50–60 hours are described as materially lighter than the classic 80-hour general-surgery grind, and attending life is usually gentler still.12 It's frequently named as one of the few surgical lifestyles you can actually plan a family around.

The trade is structural rather than about the daily hours: it is the referral-dependent, geographically concentrated job market (see Compensation and the FLI angle). And the "protected" schedule has a condition attached: it assumes a focused endocrine practice. Take a broader community general-surgery job to keep busy, and you may still share general and trauma call, since the civilized rhythm belongs to the academic and high-volume endocrine role, not automatically to the title.12

The work is also physically sustainable in a way big open-cavity or trauma surgery isn't, being refined, seated-or-standing microdissection rather than long, heavy cases, which is a real reason careers here run long.2

Lifestyle rating: 4/5. High schedule control and low emergent burden for a surgical field, docked because the geography (where you can realistically get that lifestyle) is constrained by the referral-center model.

Wellbeing — the part to take seriously

Burnout: on the lower end for surgery. Endocrine surgery isn't broken out on its own in the major surveys, so this is a placement, not a measured number. The AMA's 2025 Organizational Biopsy puts general surgery, the nearest measured parent, at 43.8% against a 41.9% all-physician average, seventh of the nine specialties it names as most burned out. Medscape's 2024 report reads surgery the same direction on its own scale, among the less burned-out fields at ~45% against a 49% average. Endocrine surgery's elective, low-emergency, controllable-schedule profile lines up with the lower-burnout surgical group rather than the high-acuity end.13 ⟳

Satisfaction / would-choose-again: high. Workforce data cited in the AMA specialty profile reports that more than 95% of endocrine surgery fellowship graduates are satisfied with their jobs, one of the stronger satisfaction signals in surgery.1 The rewards people name are unusually concrete: excellent cancer cure rates while preserving voice and cosmesis, and the near-instant relief of curing a hormone-driven disease, such as a focused parathyroidectomy that reverses years of fatigue and bone loss, confirmable as cured in the OR via a rapid intraoperative PTH assay.12 ⟳

Career longevity: excellent. Low physical toll, technically refined work, and a controllable schedule make this a field people can practice well into a long career without the body-wearing attrition of higher-volume open surgery.2 If EM's quiet crux is "can you do this at 55?", endocrine surgery's answer is one of the more reassuring in the operative world.

Who's in the field (demographics)

The most complete public breakdown remains the 2009–2013 successful-applicant survey (n=56), so read these as the last solid picture rather than this year's.4

  • Women: ~54% of successful fellowship applicants (2009–2013), notably higher than the female share of general surgery overall (~24% of active general surgeons), making endocrine surgery one of the more gender-balanced, even female-leaning, surgical subspecialties. Recent classes are widely described as majority or near-majority women, though AAES has not published a current figure.414 ⟳
  • IMG: ~5% of that cohort, historically a small share.4 ⟳
  • DO: ~0% in that cohort, historically an overwhelmingly US-MD field. DO/IMG representation may have risen since in line with broader general-surgery trends, but current-cycle figures aren't published.4 ⟳
  • Race/ethnicity (2009–2013 cohort): White ~63%, Asian ~18%, Black ~13%, Hispanic ~2%, Other ~5%, so URiM (Black plus Hispanic) is roughly 15%. AAES has published no newer race/ethnicity breakdown. ACGME's Data Resource Book AY2024-25 counts active residents by specialty and race in Table C.23, but endocrine surgery is a non-ACGME fellowship and has no row there.4 ⟳

Culture, personality & the online stereotypes

Who gravitates here (a tendency, not a rule): precise, detail-oriented surgeons who genuinely enjoy fine, elegant neck and gland dissection and find endocrine physiology fascinating, the kind of person who likes that a case is a puzzle of hormones, imaging, and anatomy as much as a technical exercise. Many are academically inclined and drawn to the idea of a controllable, elective practice, and, because so much of the job is clinic and counseling, communicative and patient-facing. The AMA profile sketches the archetype as detail-oriented overachievers who are also good with people. Plenty of happy endocrine surgeons don't fit that sketch; it's the center of the distribution, not a gate. As always, plenty of people in the field do not fit any single mold.1

The reputation (community perception rather than fact, with the usual kernel of truth):

  • "The elegant, lifestyle-friendly niche of surgery." The read online is genuinely warm: refined operations, happy patients, a civilized schedule. Largely fair, with the asterisk below.
  • "Small but happy, and hard to get a job in." The recurring caution: it's referral-dependent, so you need an academic or high-volume base feeding you cases, and jobs are limited and concentrated. Real, and the honest core of the field's downside.
  • "Not real general surgery / too narrow." A dig that endocrine surgeons "gave up the big cases." Reframe: the fine, high-stakes precision (a nicked recurrent laryngeal nerve costs a voice) is a genuine expertise, and the narrowness is exactly what buys the lifestyle.
  • "Basically thyroids all day." Repetitive to some and meditative mastery to others, and it undersells the adrenal, neuroendocrine, and hereditary-syndrome complexity at the deep end.

What people say online (synthesized and paraphrased, not quotes): across trainee and physician forums the picture is warmly positive and fairly consistent. People describe it as one of the few surgical lifestyles you can actually plan a family around, with high satisfaction and low burnout. The steady caution is the job market: the field is small, positions are relatively scarce and skew toward academic/high-volume centers, and building a referral base takes time, so early-career geography can be constrained. A common thread is that many "endocrine" surgeons in the community still do bread-and-butter general surgery to fill their schedules, and a purely endocrine practice is more of an academic or high-volume-center thing. The through-line: a genuinely happy niche, but go in clear-eyed about the market.2

Voices from the field. Paraphrased from public writing, with links to the originals:

  • Dr. Krishnamurthy, in the AMA's "Shadowing" profile, describes true endocrine emergencies as rare, nights and weekends as relatively free, and cases as mostly short and often outpatient, framing the reward as curing cancer while preserving function and cosmesis, and reversing hormone-driven disease, with fellowship-graduate satisfaction above 95%.1
  • The AAES resident brochure frames the field around thyroid, parathyroid, adrenal, and neuroendocrine disease, emphasizes advanced minimally invasive and ablative techniques and multidisciplinary practice, and argues rising diagnosis of endocrine conditions is growing demand.2
  • Endocrine-surgery workforce studies in Surgery characterize the market as small and evolving, with demand tied to referral volume and positions clustering where case volume exists, the empirical backbone of the "small but concentrated" reputation.1516

Why people choose it / why people leave

Why choose it: one of the most controllable surgical lifestyles (elective, outpatient-heavy, minimal emergent call) · high job satisfaction and low burnout for surgery · immediate, gratifying outcomes, curing hormone-driven disease and endocrine cancers with excellent survival · technically elegant, low-physical-toll work that supports a long career · a short training tail (one fellowship year on top of general surgery) · a tight-knit, supportive small society · solid surgeon-level pay.

Why leave or avoid it: small, referral-dependent field that needs a steady case pipeline (usually academic/high-volume) · geographically concentrated jobs, so you may not get to live where you want, especially early · case mix can feel narrow/repetitive if you crave variety or big open cases · many community "endocrine" surgeons still do general surgery to stay busy · referral-heavy reoperative cases (fixing others' failed operations) mean high-stakes redo dissections and lots of counseling · wRVU pay models can undercount the volume you actually do · you must get through a full general surgery residency first.

Best fit if: you love fine, precise dissection and the physiology puzzle of hormones + imaging + anatomy · you want a surgeon's career with a plannable life and low emergency burden · you're comfortable being academically oriented and/or relocating to where the volume is · you enjoy clinic, longitudinal relationships, and multidisciplinary work.

Not for you if: you want maximum geographic flexibility or a purely rural/community practice · you crave high-adrenaline, unpredictable, big-open or trauma surgery · you dislike depending on referrals and building a practice slowly · you want the broadest possible day-to-day variety of cases.

The FLI angle — Endocrine Surgery for first-gen, low-income & immigrant students

Where endocrine surgery fits FLI realities well:

  • A controllable, sustainable surgical niche with strong pay and a short add-on. It's reachable via general surgery plus one fellowship year, a shorter and cheaper tail than many fellowships, with a lifestyle that actually lets you have a life and support family. For a student weighing whether a surgical career is compatible with caregiving or family obligations, this is one of the more realistic answers in the operative world.
  • Low burnout, long career. The low physical toll and controllable, elective schedule mean the earnings can last decades without the body-wearing attrition of high-volume open surgery, so it is durable income rather than only high income.
  • A relatively gender-balanced, less-brutal surgical culture than the stereotype of surgery, which can matter for students who don't see themselves reflected in the classic surgical mold.

Risks to name honestly:

  • The catch is structural, not personal: geography. Because the field is niche and referral-dependent, the best (and most purely-endocrine) jobs concentrate at academic and high-volume centers, which can constrain where you live. If your geography is tied to family, cost of living, immigration status, or a support network, weigh that seriously; this is the field's real cost for FLI students, and it's not something hustle fixes.
  • The pipeline is long and front-loaded. You must first get through a full, competitive 5-year general surgery residency. You don't reach endocrine surgery straight from med school, and you're committing to the surgical track before you can subspecialize. That's a long runway before the "controllable" attending life arrives.
  • Historically a narrow-access field. The last published cohort was ~95% US-MD with almost no DO or IMG representation. That may be shifting, but if you're a DO or IMG applicant, the honest read is that this has not historically been one of the more open subspecialties.
  • A pragmatic fallback exists. If geography is a hard constraint, many surgeons do endocrine work alongside community general surgery, keeping some of the case mix without needing to move to a referral hub, at the cost of a purer (and more protected) endocrine practice.

Bottom line: endocrine surgery is a low-burnout, high-satisfaction, long-career surgical path with a manageable training tail and strong pay, genuinely one of the more livable surgeon lives. The honest FLI catch is that a focused endocrine practice lives at academic and high-volume centers, rather than anything about the work or the hours, so you trade some geographic freedom for the lifestyle. If you're flexible about location, or comfortable doing some general surgery alongside, it's a strong target. Shadow an endocrine surgeon's full week (OR and clinic) before you commit, and ask them frankly how the job search went.

Sub-subspecialties & areas of focus

Endocrine surgeons cover the breadth but often skew toward one area:2

  • Thyroid & parathyroid. The high-volume core; short, often outpatient operations; the source of most of the "controllable lifestyle" reputation. Increasingly minimally invasive (focused parathyroidectomy; in some centers remote-access/"scarless" and ablative techniques).
  • Adrenal. Laparoscopic/minimally invasive adrenalectomy for functional tumors (aldosteronoma, Cushing's, pheochromocytoma); somewhat higher acuity and complexity than thyroid/parathyroid.
  • Neuroendocrine. Tumors of the pancreas and GI tract; overlaps with surgical oncology/HPB and tends to be the most complex, higher-morbidity end.
  • Hereditary endocrine syndromes. MEN1/MEN2, familial medullary thyroid cancer, familial hyperparathyroidism; genetics-driven, prophylactic and multi-gland surgery, strongly multidisciplinary and academic-flavored.

Note on structure: unlike a base residency, these are informal areas of emphasis within a single fellowship, not separate accredited tracks.

Fun facts

  • A one-year add-on. Unlike many surgical subspecialties, comprehensive endocrine surgery is typically a single fellowship year after general surgery, a short tail for a big lifestyle upgrade.3
  • The cure is often instant. A focused parathyroidectomy can be confirmed cured in the OR via a rapid intraoperative PTH assay, and patients can feel dramatically better within days.12
  • Voice is the currency. So much of thyroid surgery is about protecting the recurrent laryngeal nerve that intraoperative nerve monitoring has become routine, and the fine, "don't-nick-it" precision is most of the job.2
  • Roughly gender-balanced. Noted for close to 50/50 gender representation among fellowship graduates, unusual for surgery.4
  • Small and clubby. One of surgery's smaller communities (the AAES is a compact society), tight-knit and supportive but a limited, concentrated job market.2
  • Non-ACGME, general-surgery boarded. It's a fellowship-defined subspecialty accredited by its own society (AAES) with no separate board certificate, so you practice as a general surgeon who subspecializes.3

Sources

Footnotes

  1. AMA, "What it's like to be in endocrine surgery: Shadowing Dr. Krishnamurthy" (2021) — lifestyle (rare emergencies, free-ish nights/weekends, short outpatient cases), >95% fellowship-graduate satisfaction, rewards (cancer cure with voice/cosmesis preservation; reversing hormone-driven disease), archetype/personality. https://www.ama-assn.org/medical-students/preparing-residency/what-its-be-endocrine-surgery-shadowing-dr-krishnamurthy ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11

  2. AAES, "Explore a Career in Endocrine Surgery" (resident informational brochure) — scope (thyroid/parathyroid/adrenal/neuroendocrine), minimally invasive/ablative techniques, multidisciplinary practice, volume-safety relationship, growing demand, nerve monitoring, sub-focus areas. https://www.endocrinesurgery.org/assets/Fellowships/AAES-Informational-Brochure-Residents.pdf (accessed 2026) ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15 ↩16 ↩17 ↩18

  3. Training pathway, AAES (non-ACGME) accreditation, AAES match, general-surgery (ABS) boarding with no separate endocrine certificate, 1-yr (optional 2nd yr) duration, program/position counts. AAES Fellowships page (https://www.endocrinesurgery.org/fellowships); AAES Fellowship Match Program page (https://www.endocrinesurgery.org/match-program); AAES 2023 Match (https://aaes.memberclicks.net/2023-match); AAES Match portal (https://aaesmatch.secure-platform.com/site); AAES Informational Brochure for Residents (https://www.endocrinesurgery.org/assets/Fellowships/AAES-Informational-Brochure-Residents.pdf); MD Anderson Surgical Endocrinology Fellowship (duration/accreditation) (https://www.mdanderson.org/education-training/clinical-training/graduate-medical-education/residencies-fellowships/surgical-endocrinology.html). All accessed 2026. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11

  4. "The Profile of Successful Applicants for Endocrine Surgery Fellowships: Results of a National Survey," Surgery (2015 publication; 2009–2013 fellow cohort, n=56) — 100% first-attempt match, 96% within top-5 programs, 5% intended endocrine surgery entering residency, applicant academic profile (median 5 pubs, 62% research time, 26% AOA, 77% AAES letter), and demographics (~54% women; ~95% US-MD/5% IMG/0% DO; race/ethnicity ~63% White/18% Asian/13% Black/2% Hispanic/5% Other; URiM ≈15%). https://pmc.ncbi.nlm.nih.gov/articles/PMC4639920/ Corrected 2026-08-17: the dashboard's women row said "the last published cohort" with no year, while the DO/IMG row directly beneath it dated itself. The cohort is 2009–2013 and the demographics section says so plainly; only the dashboard row hid it, and the dashboard is the part a reader quotes. The year is now on both rows. Every figure in this footnote was verified verbatim at PMC4639920, the 54% included. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9

  5. Endocrine Surgery compensation synthesis and data caveat (no survey breaks out endocrine surgery; anchor to general surgery; academic tilt; volume as the lever; referral-driven urban clustering; synthesized ~$400k–$550k range). Compiled endocrine-surgery compensation research (mid-2026), drawing on the general-surgery anchors and setting bands in this list. Corrected 2026-08-17: the general-surgery anchor sentence carried a third figure, "$475,000 median (FastRVU 2026 benchmark)," which no footnote in this file cited, so it reached the reader as an uncited dollar amount. FastRVU is also on the compensation standard's removed-outright list, so the figure is deleted rather than given a citation. The two anchors that remain, Medscape and Doximity, are the ones the sentence's argument rested on. ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  6. Medscape Physician Compensation Report 2025 — general surgery ~$442,000. Via Becker's (https://www.beckershospitalreview.com/compensation-issues/29-physician-specialties-ranked-by-annual-compensation-medscape/); overview (https://www.medscape.com/slideshow/2025-compensation-overview-6018103). (2025) ↩ ↩2

  7. Doximity 2025 Physician Compensation Report (2024 data) — general surgery $482,574; overall pay +3.7% in 2024; ~84% of surgeons report overwork. Via Fierce Healthcare (https://www.fiercehealthcare.com/finance/physician-pay-sees-modest-37-bump-2024-here-are-pay-ranking-metro-area-and-specialty); report (https://www.doximity.com/reports/physician-compensation-report/2025). ↩ ↩2

  8. By-setting compensation bands (academic $350–450k; community/employed $400–500k; private/partnership $500–700k+), highest-paying states (CA, NY, NJ, WA, FL), and rural or shortage premiums of roughly 20–30%. Previously cited to a Med Salary Data / S10.AI 2026 surgeon report, which is now dead. It was an aggregator blog rather than a compensation survey, so it has not been replaced with an equivalent source. Treat these as an order of magnitude rather than survey medians, and replace them if a real survey line appears. ⟳ Note added 2026-08-17: the compensation standard's rule for an excluded aggregator is that the figure gets removed and re-researched from scratch rather than caveated, and medsalarydata is on that list. The caveat is now visible in the dashboard row and in the body sentence, so a reader who never opens this footnote is no longer given three bands as though they were survey medians. The deletion itself is held: these are the only by-setting compensation figures on the page, and whether to remove numbers with nothing to put in their place has since been settled by keeping the figure and naming the host in the visible sentence. ↩ ↩2

  9. AAES, "Statement on clinical productivity and compensation for endocrine surgeons," Surgery (2026) — wRVU-based models can disadvantage endocrine surgeons because high-volume short outpatient cases generate fewer wRVUs/hour. https://www.sciencedirect.com/science/article/pii/S0039606026002345 (specific thresholds paywalled — verify) ↩

  10. ZipRecruiter "Endocrine Surgeon" (US, 2026) — national avg ~$285,176, range $100k–$399k, ~$137/hr; flagged as an understated aggregator outlier (mixed/mislabeled postings), not the fellowship-trained norm. https://www.ziprecruiter.com/Salaries/Endocrine-Surgeon-Salary ↩

  11. Medscape Physician Compensation Report 2026 ("return to normalization"; gains barely outpacing inflation; all-physician ~$386k, specialists ~$417k). Via Weatherby (https://weatherbyhealthcare.com/blog/annual-physician-salary-report); report (https://www.medscape.com/p11/return-normalization-medscape-physician-compensation-report-2026a10009um). (2026) ↩

  12. ACS Brief (May 2026) — 2.5% wRVU cut on nearly all non-time-based CPT codes effective Jan 1, 2026, and benchmark-recalibration discussion. https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/acs-brief/may-5-2026-issue/surgeons-describe-solutions-for-recalibrating-productivity-benchmarks-in-face-of-wrvu-cuts/ (2026) ↩

  13. Burnout. AMA Organizational Biopsy 2025 (~19,000 physician responses, 106 health systems, 38 states) puts General surgery at 43.8% against a 41.9% all-physician average, seventh of the nine specialties it names as most burned out, https://www.ama-assn.org/practice-management/physician-health/these-9-physician-specialties-report-highest-burnout-rates. Corrected 2026-08-17: the dashboard, the body and the wellbeing figure now lead with the AMA row rather than Medscape's ~45%, and endocrine surgery is not broken out by either instrument, so the parent remains a placement rather than a measurement. The two baselines are seven points apart and never share a sentence. The Medscape reading kept beside it: Physician Burnout & Depression Report 2024 — "surgery" ~45% (lower-burnout group; plastics 37% lowest, EM 63% highest); endocrine surgery not broken out separately. Via Healthgrades summary (https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty); Medscape index (https://www.medscape.com/sites/public/lifestyle/2024). (2024) ↩

  14. General surgery ~24% women (active physicians, comparison point). AAMC Physician Specialty Data Report (2022 data). https://web.archive.org/web/20250112142220/https://www.aamc.org/data-reports/workforce/data/active-physicians-sex-specialty-2021 ↩

  15. Wang TS et al., "The endocrine surgery job market: a survey of fellows, department chairs, and surgery recruiters," Surgery (2013) — small, referral-driven, volume-clustered market. https://pubmed.ncbi.nlm.nih.gov/23618449/ ↩

  16. Zarebczan Dull B et al., "Endocrine surgery fellowship graduates past, present, and future: 8 years of early job market experiences," Surgery (2016) — early-career placement over multiple graduate cohorts. https://pubmed.ncbi.nlm.nih.gov/27866719/ ↩

Researched with AI assistance and reviewed by hand. How this site is made